France
# |
Name |
Net Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
11.73%
|
Dec. 31, 2023 | USD 96.09 | -1.23% |
|
France |
|
2 |
-65.99%
|
Dec. 31, 2023 | USD 2.16 | -2.19% |
|
France |
|
3 |
-462.40%
|
Dec. 31, 2023 | USD 4.64 | -14.23% |
|
France |
|
4 |
-1,032.91%
|
Dec. 31, 2023 | USD 6.91 | 0.46% |
|
France |
|
5 |
-1,639.16%
|
Dec. 31, 2023 | USD 0.96 | -6.39% |
|
France |
The Vaccines company in France with the highest Net Income Margin is Sanofi (Paris Stock Exchange: SAN.PA) at 11.73%.
The Vaccines company in France with the lowest Net Income Margin is Neovacs S.A. (Paris Stock Exchange: ALNEV.PA) at -1,639.16%.
The top 10 Vaccines companies in France by Net Income Margin are Sanofi, Valneva SE, DBV Technologies S.A., OSE Immunotherapeutics SA and Neovacs S.A..
The bottom 10 Vaccines companies in France by Net Income Margin are Neovacs S.A., OSE Immunotherapeutics SA, DBV Technologies S.A., Valneva SE and Sanofi.